BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 21561789)

  • 21. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
    Tzeng HT; Chyuan IT; Lai JH
    Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SnapShot: Jak-STAT Signaling II.
    Villarino AV; Gadina M; O'Shea JJ; Kanno Y
    Cell; 2020 Jun; 181(7):1696-1696.e1. PubMed ID: 32589961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms.
    Liu J; Wang F; Luo F
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JAK/STAT in leukemia: a clinical update.
    Liang D; Wang Q; Zhang W; Tang H; Song C; Yan Z; Liang Y; Wang H
    Mol Cancer; 2024 Jan; 23(1):25. PubMed ID: 38273387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inborn errors of human JAKs and STATs.
    Casanova JL; Holland SM; Notarangelo LD
    Immunity; 2012 Apr; 36(4):515-28. PubMed ID: 22520845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK/STAT signaling regulates the Harmonia axyridis leg regeneration by coordinating cell proliferation.
    Zhou H; Wang W; Yan S; Zhang J; Wang D; Shen J
    Dev Biol; 2022 Mar; 483():98-106. PubMed ID: 34999052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The regulation of JAKs in cytokine signaling and its breakdown in disease.
    Hammarén HM; Virtanen AT; Raivola J; Silvennoinen O
    Cytokine; 2019 Jun; 118():48-63. PubMed ID: 29685781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK/Stat signaling regulates heart precursor diversification in Drosophila.
    Johnson AN; Mokalled MH; Haden TN; Olson EN
    Development; 2011 Nov; 138(21):4627-38. PubMed ID: 21965617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
    O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
    Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK/STAT pathway regulation of GABAA receptor expression after differing severities of experimental TBI.
    Raible DJ; Frey LC; Del Angel YC; Carlsen J; Hund D; Russek SJ; Smith B; Brooks-Kayal AR
    Exp Neurol; 2015 Sep; 271():445-56. PubMed ID: 26172316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
    Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Non-Receptor Protein Tyrosine Phosphatase PTPN6 Mediates a Positive Regulatory Approach From the Interferon Regulatory Factor to the JAK/STAT Pathway in
    Luo M; Xu X; Liu X; Shen W; Yang L; Zhu Z; Weng S; He J; Zuo H
    Front Immunol; 2022; 13():913955. PubMed ID: 35844582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
    Pérez C; González-Rincón J; Onaindia A; Almaráz C; García-Díaz N; Pisonero H; Curiel-Olmo S; Gómez S; Cereceda L; Madureira R; Hospital M; Suárez-Massa D; Rodriguez-Peralto JL; Postigo C; Leon-Castillo A; González-Vela C; Martinez N; Ortiz-Romero P; Sánchez-Beato M; Piris MÁ; Vaqué JP
    Haematologica; 2015 Nov; 100(11):e450-3. PubMed ID: 26294736
    [No Abstract]   [Full Text] [Related]  

  • 35. [JAK/STAT: from inflammation to memory].
    Nicolas CS; Csaba Z; Fafouri A; Javalet C; Gressens P; Dournaud P; Peineau S
    Med Sci (Paris); 2012 May; 28(5):456-8. PubMed ID: 22642993
    [No Abstract]   [Full Text] [Related]  

  • 36. Evolution of JAK-STAT pathway components: mechanisms and role in immune system development.
    Liongue C; O'Sullivan LA; Trengove MC; Ward AC
    PLoS One; 2012; 7(3):e32777. PubMed ID: 22412924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of JAK-STAT signaling pathway genes and their microRNAs in the intestinal mucosa of genetically disparate chicken lines induced with necrotic enteritis.
    Truong AD; Rengaraj D; Hong Y; Hoang CT; Hong YH; Lillehoj HS
    Vet Immunol Immunopathol; 2017 May; 187():1-9. PubMed ID: 28494922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAK-STAT signaling pathway in non-infectious uveitis.
    Su Y; Tao T; Liu X; Su W
    Biochem Pharmacol; 2022 Oct; 204():115236. PubMed ID: 36041544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAKs and STATs in immunity, immunodeficiency, and cancer.
    O'Shea JJ; Holland SM; Staudt LM
    N Engl J Med; 2013 Jan; 368(2):161-70. PubMed ID: 23301733
    [No Abstract]   [Full Text] [Related]  

  • 40. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.